EN 
JA CLINICAL DATA
Heart Support Net + Clinical Study Results
Based on the shape and condition of each patient's heart
Designed and manufactured by
Dilated cardiomyopathy.New treatment methods
Cardiac Assist Net is a product under research and development for the treatment of sudden onset dilated cardiomyopathy (hereinafter referred to as "dilated cardiomyopathy") with the aim of "delaying the progression of symptoms and improving exercise function.
Dilated cardiomyopathy is a disease in which the heart muscle expands to compensate for the heart's reduced function, instead placing a greater burden on the heart. The goal of the treatment is to "improve heart function while suppressing the dilation of the left ventricle" by covering it with a net tailored to each patient's heart. The results of the study showed that in all three cases, heart failure symptoms improved and exercise function improved.
We are developing this innovative treatment for dilated cardiomyopathy by applying the latest technology, which currently has only special treatment options such as waiting until end-stage heart failure to "implant an artificial heart" or "perform a heart transplant surgery".
Prevent further enlargement of the heart,
Supports heart contraction
The tailor-made method
Cardiac Assist Net
Cardiac Assist Net is a tailor-made system. It is designed and manufactured according to the shape and condition of the patient's heart. The net is created based on the image data of each patient in advance, so that it fits the heart and applies appropriate support pressure to prevent heart enlargement.
The surgery is relatively short, taking only two hours, and greatly reduces the risk of infection and complications, as well as the patient's physical burden.
By utilizing new medical technologies and knowledge, we aim to provide treatments that minimize the risks to patients while aiming for a large effect. Cardiac Support Net conducts research and development not only for dilated cardiomyopathy itself, but also for "improving the quality of life" of patients.
Summary of Clinical Studies
CLINICAL DATA
- Three NYHA-III dilated cardiomyopathy patients aged 65 years or older who were off-label for heart transplantation were fitted with a TaylorMade cardiac shape correcting net, and no adverse events related to the study device occurred.
- Evaluation at 24 weeks postoperatively showed marked improvement in pulmonary congestion and significant improvement in exercise tolerance, and the improvement in exercise function has been maintained at 1 year postoperatively.
- As a result, it was decided to move on to an exploratory investigator-initiated clinical trial (the "clinical trial" you have heard so much about).
CONTACT
Contact Us
About the Cardiac Support Net treatment and,
Clinical trials, etc.
Please feel free to contact us for any inquiries.
